Fast axonal transport: A site of acrylamide neurotoxicity?

NeuroToxicology

Volumn 23, Issue 2, 2002, Pages 223-251

  Sickles, Dale W ^a   Stone, J Derek ^a   Friedman, Marvin A ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Acrylamide; Fast axonal transport; Kinesin; Neurotoxicity

Indexed keywords

ACRYLAMIDE;

CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; MEASUREMENT; MICROTUBULE; NERVE FIBER TRANSPORT; NEUROFILAMENT; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT; ACTIVE TRANSPORT; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; NERVE FIBER; PHYSIOLOGY; REVIEW;

ACRYLAMIDE; ANIMAL; AXONAL TRANSPORT; AXONS; BIOLOGICAL TRANSPORT, ACTIVE; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0036628684     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00025-6     Document Type: Conference Paper

References (189)

1. Video-enhanced contrast, differential interference contrast (AVEC-DIC) microscopy: A new method capable of analyzing microtubule-related motility in the reticulopodial network of
2. Fast axonal transport in squid giant axon
3. The effect of 3,4-dimethyl substitution on neurotoxicity of 2,5-hexanedione. Part II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking
4. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. Part I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings
5. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat
6. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide
7. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide
8. Acrylamide neuropathy: Changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons
9. The discovery of kinesin: An historical perspective
10. Axoplasmic flow in cats with toxic neuropathies. Part I. Axoplasmic flow in cats with toxic neuropathies
11. A novel brain ATPase with properties expected for the fast axonal transport motor
12. Molecular motors in the nervous system
13. A kinesin medley: Biochemical and functional heterogeneity
14. Kinesin interactions with membrane bounded organelles in vivo and in vitro
15. Biochemical and functional diversity of microtubule motors in the nervous system
16. Video microscopy of fast axonal transport in extruded axoplasm: A new model for study of molecular mechanisms
17. A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm
18. Acrylamide and glycidamide impair outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bi-directional transport of organelles observed by video microscopy
19. Acrylamide neuropathy in the rat: Effects on energy metabolism in sciatic nerve
20. 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins
21. 14C] acrylamide to proteins in the mouse nervous system
22. The significance of the dying-back process in experimental and human neurological disease
23. On the pattern of changes in the rat nervous system produced by 2,5-hexanediol
24. Ultrastructural features of the Purkinje cell damage caused by acrylamide in the rat: A new phenomenon in cellular neuropathology
25. Acrylamide-induced neuropathy and impairment of axonal transport of proteins. Part II. Abnormal accumulations of smooth endoplasmic reticulum as sites of focal retention of fast-transported pro
26. Decreased GAP-43 accumulation in neurite tips of cultured hippocampal neurons by acrylamide
27. Occupational exposure to the neurotoxicant acrylamide: Health effects and hemoglobin adducts
28. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
29. Acrylamide neuropathy and changes in the axonal transport and muscular content of the molecular forms of acetylcholinesterase
30. The impact of dose rate on the neurotoxicity of acrylamide: The interaction of administered dose, target tissue concentrations, tissue damage, and functional effects
31. Molecular genetics of kinesin light chains: Generations of isoforms by alternative splicing
32. The axonal transport motor kinesin is bound to anterogradely-transported organelles: Quantitative cytofluorimetric studies of fast axonal transport in the rat
33. Organelles in fast axonal transport
34. Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity and carcinogenicity
35. Molecular mechanisms of diketone neurotoxicity
36. Neurotoxicity and protein binding of 2,5-hexanedione in the hen
37. The distribution and metabolism of acrylamide and its neurotoxic analogues in rats
38. Fast axonal transport of kinesin in the rat visual system: Functionality of kinesin heavy chain isoforms
39. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofialment-B-galactosidase fusion protein
40. Heterogeneous visceral changes in acrylamide intoxication
41. Peripheral neuropathy in rats produced by acrylamide
42. Six cases of acrylamide poisoning
43. Effects of kinesin mutations on neuronal functions
44. Axonal degeneration and axonal caliber alterations following combined β, β′-iminodipropionitrile (IDPN) and acrylamide administration
45. Slow axonal transport in acrylamide neuropathy: Different abnormalities produced by single-dose and continuous administration
46. Group Ia primary afferent terminal defect in cats with acrylamide neuropathy
47. Intra-cellular transport in neurons
48. In vitro and in vivo studies of the molecular pathogenesis of n-hexane neuropathy
49. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy
50. Molecular mechanisms of Γ-diketone neuropathy
51. Proximal axonopathies induced by toxic chemicals
52. Slow axonal transport of neurofilament proteins: Impairment by β,β′-iminodipropionitrile administration
53. Axonal transport of neurofilament proteins in IDPN neurotoxicity
54. Acrylamide and carbon disulfide treatments increase the rate of rat brain tubulin polymerization
55. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part V. Reduced bi-directional vesicle transport in cultured neurons by acrylamide and glycidamide
56. Acrylamide effects on cAMP-dependent MAP phosphorylation and microtubule disassembly
57. Acrylamide-induced alterations in axonal transport. Biochemical and autoradiographic studies
58. Acrylamide-induced increases in deposition of axonally-transported glycoproteins in rat sciatic nerve
59. Acrylamide exposure preferentially impairs axonal transport of glycoproteins in myelinated axons
60. Biochemical studies on acrylamide, a neurotoxic agent
61. Alteration of amino acid incorporation into proteins of the nervous system in vitro after administration of acrylamide to rats
62. Distribution and binding studies of acrylamide
63. Cytotoxic effects of acrylamide and its related compounds assessed by protein content, LDH activity and cumulative glucose consumption of neuron-rich cultures in a chemically defined
64. The neurobiology of Alzheimer's disease
65. 270 K Microtubule-associated protein cross-reacting with anti-MAP2 IgG in the crayfish peripheral nerve axon
66. Kinesin and dynein superfamily proteins and the mechanism of organelle transport
67. Submolecular domains of bovine brain kinesin identified by electron microscopy and monoclonal antibody decoration
68. Brain dynein (MAP 1C) localizes on both anterogradely and retrogradely-transported membranous organelles in vivo
69. Kinesin associates with anterogradely-transported membranous organelles in vivo
70. Control of axonal caliber by neurofilament transport
71. Slowing of neurofilament transport and the radial growth of developing nerve fibers
72. The distribution, abundance and subcellular localization of kinesin
73. Dyneins: Molecular structure and cellular function
74. The effect of acrylamide on the peripheral nervous system of the baboon
75. The etiology of acrylamide neuropathy: Enolase, phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase activities in peripheral nerve, spinal cord, brain, and skeletal
76. Neuron specific enolase: Investigation on its possible retrograde axonal transport
77. The etiology of toxic peripheral neuropathies: In vitro effects of acrylamide and 2,5-hexanedione on brain enolase and other glycolytic enzymes
78. The etiology of acrylamide neuropathy: Possible involvement of neuron specific enolase
79. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila
80. Early and dose dependent decrease of retrograde axonal transport in acrylamide intoxicated rats
81. A proposal for a classification of neuropathies according to their axonal transport abnormalities
82. Effects of acrylamide and botulinum toxin on horseradish peroxidase labeling of trigeminal motor neurons in the rat
83. Crosslinking of neurofilament proteins of rat spinal cord in vivo after administration of 2,5-hexanedione
84. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy
85. 14C]acrylamide to neurofilament and microtubule proteins of rats
86. 3H]-L-leucine
87. Biochemical and morphologic characterization of acrylamide peripheral neuropathy
88. Acrylamide
89. Physiologic and pathologic changes in acrylamide neuropathy
90. The effect of organophosphates on a chicken brain or sea urchin egg kinesin-driven microtubule motility assay
91. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: Analysis by two-dimensional polyacrylamide gel
92. Glucose-dependent lactate production by homogenates of neuronal tissues prepared from rats treated with 2,4-dithiobiuret, acrylamide, p-bromophenylacetylurea and 2,5-hexanedione
93. A quantitation of fast axonal transport in cultured chick dorsal root ganglion (DRG) explants following exposure to acrylamide (ACR), methacrylamide (M-ACR) and cyanide
94. The effect of acrylamide and other sulfhydryl alkylators on the ability of dynein and kinesin to translocate microtubules in vitro
95. Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration
96. Single doses of acrylamide reduce retrograde transport velocity
97. The mechanisms of acrylamide axonopathy
98. Pharmacokinectics of acrylamide in Fisher-334 rats
99. Altered retrograde axonal transport of nerve growth factor after single and repeated doses of acrylamide in the rat
100. The role of microtubule polarity in the movement of kinesin and kinetochores
101. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication
102. Giant axonopahty characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport
103. Kinesin proteins: A phylum of motors for microtubule-based motility
104. Progressive deficits in retrograde axon transport precede degeneration of motor axons in acrylamide neuropathy
105. Effects of acrylamide on cotransmission in perivascular sympathetic and sensory nerves
106. The effect of acrylamide on the induction of ornithine decarboxylase in the dorsal root ganlion of the rat
107. Toxic neuropathy: An overview
108. The action of neurotoxins in relation to axoplasmic transport
109. Dependence of fast axoplasmic transport in nerve on oxidative metabolism
110. Direct measurement of fast axonal organelle transport in the sciatic nerve of rats treated with acrylamide
111. Reorganization of axoplasmic organelles following β,β′-iminodipropionitrile administration
112. Redistribution of proteins of fast axonal transport following administration of β, β′-iminodipropionitrile: A quantitative autoradiographic study
113. Selective interruption of axonal transport of neurofilament proteins in the visual system by β,β′-iminodipropionitrile (IDPN) intoxication
114. Retrograde transport by the microtubule associated protein MAP 1C
115. MAP 1C is a microtubule-activated ATPase which translocates microtubules in vitro and has dynein-like properties
116. Purification of brain cytoplasmic dynein and characterization of its in vitro properties
117. Modification of the microtubule-binding and ATPase activities of kinesin by N-ethylmaleimide (NEM) suggests a role of sulfhydryls in fast axonal transport
118. Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells
119. Acrylamide autonomic neuropathy in the cat. Part I. Neurophysiological and histological studies
120. Acrylamide autonomic neuropathy in the cat. Part 2. Effects on mesenteric vascular control
121. The pathogenesis of dying-back polyneuropathies. Part 2. An ultrastructural study of experimental acrylamide intoxication in the cat
122. Acrylamide-induced autonomic neuropathy of rat mesenteric vessels: Histological and pharmacological studies
123. Studies on axoplasmic transport of individual proteins. Part I. Acetylcholinesterase in acrylamide neuropathy
124. Determination of acrylamide in rat serum and sciatic nerve by gas chromatography-electron-capture detection
125. Microtubules with altered assembly kinetics have a decreased rate of kinesin-based transport
126. Action of acrylamide on selected enzymes of energy metabolism in denervated cat peripheral nerves
127. Acrylamide impairs fast and slow axonal transport in rat optic system
128. Acrylamide and 2,5-hexanedione neuropathies: Abnormal bi-directional transport rate in distal axons
129. Effect of acrylamide and related compounds on glycolytic enzymes in mouse brain in vitro
130. Effect of acrylamide and related compounds on glycolytic enzymes in rat sciatic nerve in vivo
131. Abnormalities in the vagus nerve in canine acrylamide neuropathy
132. Kinesin heavy chain is essential for viability and neuromuscular functions in Drosophila, but mutants show no defects in mitosis
133. Pathogenesis of experimental giant neurofilamentous axonopathies: A unified hypothesis based on chemical modification of neurofilaments
134. Ultrastructural studies of the dying-back process. Part I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication
135. Dynein is the motor for retrograde axonal transport of organelles
136. Kinesin is bound with high affinity to squid axon organelles that move to the plus-end of microtubules
137. Polyneuropathies and CNS protein metabolism. Part II. Changes in the incorporation rate of leucine during acrylamide intoxication
138. Polyneuropathies and CNS protein metabolism. Part III. Changes in protein synthesis rate induced by acrylamide intoxication
139. Motors for fast axonal transport
140. The mechanism and regulation of fast axonal transport
141. Intermediate filaments and steroidogenesis in adrenal Y-1 cells: Acrylamide stimulation of steroid production
142. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part I. The effects of single doses of acrylamide on the rate and capacity of transport
143. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part II. The effects of single doses of neurotoxic and non-neurotoxic diketones and β,β′-iminodipropionitrile (IDPN) on the rate and capacity of transport
144. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione
145. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part IV. In vitro analysis of transport following acrylamide and 2,5-hexanedione
146. Acrylamide alters oxidative enzyme activity in rat motoneurons
147. Acrylamide produces a direct, dose-dependent and specific inhibition of oxidative metabolism in motoneurons
148. Effects of neurofilamentous axonopathy-producing neurotoxicants on in vitro production of ATP by brain mitochondria
149. Toxic axonal degeneration occurs independent of neurofilament proteins
150. Acrylamide arrests mitosis and prevents chromosome migration in the absence of changes in spindle microtubules
151. Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility
152. Acrylamide produces a temporal and correlative decrease in fast anterogradely-transported proteins in neuromuscular junctions
153. Anterograde axonal transport in rats during intoxication with acrylamide
154. Real-time imaging of axonally-transported subresolution organelles in vertebrate myelinated axons
155. Acrylamide and polyacrylamide: A review of production, use, environmental fate and neurotoxicity
156. Acrylamide-induced neuropathy and impairment of axonal transport of proteins. Part I. Multifocal retention of fast-transported proteins at the periphery of axons as revealed by light microscope
157. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure
158. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms
159. Nervous system degeneration produced by acrylamide monomer
160. Central-peripheral distal axonopathy: The pathology of dying-back polyneuropathies
161. Ultrastructural studies of the dying-back process. Part 4. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies
162. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies?
163. Pyrrole oxidation and protein cross-linking as necessary steps in the development of γ-diketone neuropathy
164. Neurofilament protein crosslinking in gamma-diketone neuropathy: In vitro and in vivo studies using the seaworm Myxicola infundibulum
165. Acrylamide induces early morphologic reorganization of neuronal cell body
166. The role of the neuronal cell body in neurotoxic injury
167. Altered sensory ganglia in acrylamide neuropathy
168. 2,5-Hexanedione and acrylamide produce reorganization of motoneuron perikarya
169. Does pyruvate prevent acrylamide neurotoxicity? Implications for disease pathogenesis
170. Axonal neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport. Part II. Video-enhanced differential interference microscopy in PNS axons
171. Axonal neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport. Part I. Radio-labeling in CNS axons
172. Axonal neurofilaments are non-essential elements in the pathogenesis of mammalian toxic neuropathies
173. Characterization and quantitation of urinary metabolites of [1,2,3-13C] acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy
174. Acrylamide-induced neurotoxicity in the central nervous system of Japanese quails. Comparative studies of normal and neurofilament-deficient quails
175. Acrylamide-induced peripheral neuropathy in normal and neurofilament-deficient Japanese quails
176. Neurotoxicity of acrylamide and related compounds in rats. Effects on rotarod performance, morphology of nerves and neurotubulin
177. Effect of acrylamide and related compounds on glycolytic enzymes of rat brain
178. The neurotoxicity of acrylamide: An overview
179. The effects of acrylamide given acutely or in repeated doses on fore and hindlimb function of rats
180. One motor, many tails: An expanding repetoire of force-generatin enzymes
181. Identifiaction of a novel force-generating protein, kinesin, involved in microtubule-based motility
182. Mechanisms of fast and slow axonal transport
183. The role of dynein in retrograde axonal transport
184. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in tissues of the rat by acrylamide and related compounds
185. The crayfish neuronal cytoskeleton: An investigation of proteins having neurofilament-like immunoreactivity
186. A crustacean neuronal cytoskeletal protein with characteristics of neurofilaments and microtubule-associated proteins
187. Inhibition of fast axoplasmic transport by acrylamide
188. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease